VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Fr

Barclays analyst Luke Sergott upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight and rai

Bloodstream infections can trigger sepsis, a life-threatening response to infection; about 1.7 milli

10x Genomics won a $4.8 million patent infringement lawsuit against Qiagen subsidiary Parse Bioscien

Jury finds Parse willfully infringed Scale Biosciences' patents and rejects Parse's invalidi

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Jonathan M. Pratt has b

QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance marke

Citigroup analyst Brendan Digan maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price

Barclays analyst Luke Sergott maintains Qiagen (NYSE:QGEN) with a Equal-Weight and raises the pri

JP Morgan analyst Casey Woodring maintains Qiagen (NYSE:QGEN) with a Overweight and raises the pr

Qiagen (NYSE:QGEN) Q3 expected to be more than $0.62 vs $0.64 Est. sees Q3 sales of $538.330 millio

Qiagen (NYSE:QGEN) FY2026 expected to be more than $2.43 vs $2.42 Est. affirms FY2026 sales outlook

Qiagen (NYSE:QGEN) reported quarterly earnings of $0.62 per share which beat the analyst consensus e

More than 1,600 U.S. cases of cyclosporiasis have been confirmed since May 2026 as infections linked

Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the

Morgan Stanley analyst Steve Beuchaw upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight

Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcui

QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))) announced at the 2026 BIO-IT World Conference &a

Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target

Co-founder and former CEO Dr. Metin Colpan to become Honorary Chairman of the Supervisory Board afte

TD Cowen analyst Dan Brennan maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target

Ambition to support high-throughput laboratories in efficiently scaling latent tuberculosis (TB) scr

Qiagen (NYSE:QGEN) FY2026 expected to be more than $2.43 vs $2.51 Est. affirms FY2026 sales outlook

JP Morgan analyst Casey Woodring maintains Qiagen (NYSE:QGEN) with a Overweight and lowers the pr

Citigroup analyst Patrick Donnelly maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the pri

Barclays analyst Luke Sergott maintains Qiagen (NYSE:QGEN) with a Equal-Weight and lowers the pri

Analysts upgraded Qiagen, Armstrong World, T-Mobile, Crane Co, and Centene Corp stocks, with price t

Analysts change outlook & ratings for QGEN, AWI, CR, ATEN, PLUG, SBUX, CECO, CNC. Price targets

Baird analyst Catherine Schulte upgrades Qiagen (NYSE:QGEN) from Neutral to Outperform and lowers

Tech stocks slide as OpenAI's user growth miss reignites AI capex skepticism, while oil rallies

Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and a

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced newly published clinical and

Deutsche Bank analyst Jan Koch upgrades Qiagen (NYSE:QGEN) from Hold to Buy and maintains the pri

QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA))) today announced that the U.S. Food and Drug

JP Morgan analyst Casey Woodring maintains Qiagen (NYSE:QGEN) with a Overweight and raises the pr

Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and raises the price target

Qiagen (NYSE:QGEN) FY2026 expected to be more than $2.50 vs $2.66 Est. FY2026 Revenue expected to

Qiagen (NYSE:QGEN) Q1 expected to be more than $0.54 vs $0.60 Est. Q1 Revenue expected to be more

Qiagen (NYSE:QGEN) reported quarterly earnings of $0.62 per share which missed the analyst consensus

Deutsche Bank analyst Jan Koch downgrades Qiagen (NYSE:QGEN) from Buy to Hold and raises the pric

Qiagen is reviewing strategic options, including a potential sale, after renewed takeover interest f

Wall Street tumbled on Tuesday, reopening after the Martin Luther King Jr. Day holiday, as risk-off